Apyx Medical Corporation (APYX) financial statements (2021 and earlier)

Company profile

Business Address 5115 ULMERTON ROAD
CLEARWATER, FL 33760
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4259781014126
Cash and cash equivalents4259161014126
Short-term investments  62    
Receivables17955532
Inventory, net of allowances, customer advances and progress billings4557666
Inventory4557666
Deposits current assets      0
Other undisclosed current assets3411112
Total current assets:66779023272215
Noncurrent Assets
Finance lease, right-of-use asset01
Operating lease, right-of-use asset00
Property, plant and equipment7766677
Intangible assets, net (including goodwill)  02220
Goodwill  0000 
Intangible assets, net (excluding goodwill)  02220
Deposits noncurrent assets  00000
Other noncurrent assets1000000
Other undisclosed noncurrent assets     02
Total noncurrent assets:8868999
TOTAL ASSETS:74859631353125
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities91254543
Accounts payable2212212
Accrued liabilities7932322
Employee-related liabilities  1111 
Debt00 0000
Due to related parties 0     
Other undisclosed current liabilities0 21  0
Total current liabilities:91286544
Noncurrent Liabilities
Long-term debt and lease obligation0102333
Long-term debt, excluding current maturities  02333
Finance lease, liability00
Operating lease, liability00
Liabilities, other than long-term debt11 0000
Deferred revenue and credits 000
Deferred revenue1 
Other liabilities01     
Derivative instruments and hedges, liabilities   00  
Other undisclosed noncurrent liabilities   11113
Total noncurrent liabilities:11034416
Total liabilities:1013899820
Stockholders' equity
Stockholders' equity attributable to parent, including:6471882226232
Preferred stock    0  
Common stock0000000
Additional paid in capital61575250504329
Retained earnings (accumulated deficit)31536(28)(23)(19)(28)
Other undisclosed stockholders' equity attributable to parent     0 
Stockholders' equity attributable to noncontrolling interest0      
Other undisclosed stockholders' equity      3
Total stockholders' equity:6471882226235
TOTAL LIABILITIES AND EQUITY:74859631353125

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues28281739373028
Revenue, net1739373028
Cost of revenue
(Cost of Goods and Services Sold)
(10)(9)(6)(19)(19)(17)(19)
Gross profit:1819112018139
Operating expenses(38)(40)(24)(25)(22)(20)(23)
Other operating expense, net  (0)    
Other undisclosed operating income  0   8
Operating loss:(20)(21)(14)(5)(4)(7)(6)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
1100(0)2(7)
Interest and debt expense(0)(0)(0)    
Loss from continuing operations before equity method investments, income taxes:(19)(20)(13)(5)(4)(5)(13)
Other undisclosed income from continuing operations before income taxes000    
Loss from continuing operations before income taxes:(19)(20)(13)(5)(4)(5)(13)
Income tax expense (benefit)8040(0)(0)(4)
Net loss:(12)(20)(9)(5)(4)(5)(17)
Net income attributable to noncontrolling interest0      
Net loss attributable to parent:(12)(20)(9)(5)(4)(5)(17)
Other undisclosed net income (loss) available to common stockholders, basic  74  14(1)
Net income (loss) available to common stockholders, basic:(12)(20)64(5)(4)8(18)
Convertible preferred dividends     11,061
Other undisclosed net loss available to common stockholders, diluted   (0)(0)(3) 
Net income (loss) available to common stockholders, diluted:(12)(20)64(5)(4)71,042

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(12)(20)(9)(5)(4)(5)(17)
Comprehensive loss:(12)(20)(9)(5)(4)(5)(17)
Comprehensive income, net of tax, attributable to noncontrolling interest0      
Comprehensive loss, net of tax, attributable to parent:(12)(20)(9)(5)(4)(5)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: